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Despite being more popular for biofuel, microalgae have gained a lot of attention as a source of biomolecules and
biomass for feed purposes. Algae farming can be established using land as well as sea and strategies can be
designed in order to gain the products of specific interest in the optimal way. A general overview of the
contributions of Algae to meet the requirements of nutrients in animal/aquaculture feed is presented in this study.
In addition to its applications in animal/aquaculture feed, algae can produce a number of biomolecules including
astaxanthin, lutein, beta-carotene, chlorophyll, phycobiliprotein, Polyunsaturated Fatty Acids (PUFAs), beta-1,3-glucan,
and pharmaceutical and nutraceutical compounds which have been reviewed with respect to their commercial
importance and current status. The review is further extended to highlight the adequate utilization of value added
products in the feeds for livestock, poultry and aquaculture (with emphasis in shrimp farming).
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Nutritional composition of algae is well documented and
it mainly contains proteins, carbohydrates, lipids and trace
nutrients, including vitamins, antioxidants, and trace ele-
ments. These all algal components have the characteristics
to be a natural supplement in human and animal feed to
replace synthetic components or meet the increasing
demands of such ingredients. Increased consumption of
animal proteins is creating a towering demand of high
quality fish and animal feed to generate healthy proteins
for humans. Fish meal is the protein source traditionally
used in aquaculture diets but it is considered as limited
and expensive. The nutritional contents of algae are rapidly
gaining importance as a renewable source to substitute the
conventional ingredients in the aquaculture/animal feed.
Algae is defined as heterogeneous assemblage of organisms
that range in size from tiny cells to giant seaweeds, thus
algae mostly are photosynthetic species which includes
eukaryotes and prokaryotic Cyanobacteria (blue-green
algae) and live in aquatic habitats. Algae can be differenti-
ated (by the body size and structure) either to microalgae
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unless otherwise stated.or to macroalgae (large enough to be seen with unaided
eye) [1]. Algae culturing has been adopted since the late
of 1800s and early 1900s, while microalgae mass cultur-
ing begin to develop since the achievement of Allen and
Nelson in 1910 by cultivating Chlorella sp. for aquacul-
ture purposes in Berlin, Germany [2]. To date, it seems
that microalgae have the potential to play pivotal roles
in order to remedy the energy, environment and food
crisis prevailing in the world. This review encompasses
the roles of algae in biomolecules production including
astaxanthin, lutein, beta carotene, chlorophyll, phycobili-
protein, Polyunsaturated Fatty Acids (PUFAs), beta-1,3-
glucan, and pharmaceutical and nutraceutical compounds.
This review also emphasizes on the utilization of these
biomolecules in livestock, poultry and aquaculture (and
especially shrimp farming) feed.Review
Production of value added products from algae
The global carotenoids market is projected to reach US
$1.2 billion by the year 2015, because of the rising con-
sumer awareness about health benefits offered by various
carotenoids, and the shift towards healthy and natural
food products (Global Industry Analysts, Inc http://www.
strategyr.com/Carotenoids_Market_Report.asp/). Accord-
ing to a recently published report, global carotenoidsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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www.prweb.com/pdfdownload/8849957.pdf). The nutra-
ceuticals boom has also integrated carotenoid mainly on
the claim of their proven antioxidant properties; caroten-
oids are usually considered important for industrial use in
food products, cosmetics as vitamin supplements, health
food products, and as feed additives for poultry, livestock,
fish, and crustaceans [3]. In contrast, carotenoid in fish oil
comes from microalgae, therefore it is logical to cultivate
microalgae for carotenoids production [4]. Del Campo et
al. [3] have reported that structure of more than 600 dif-
ferent carotenoids have been derived from a 40-carbon
polyene chain. This paper will focus on carotenoids such
as astaxanthin, lutein, beta-carotene and other high-
valued molecules which are produced by microalgae (or in
some case by macro algae) and Cyanobacteria and can be
industrialized. Moreover, microalgae play a key role in
high grade animal nutrition food from aquaculture to
farm animals. Comprehensive nutritional and toxico-
logical evaluations have demonstrated suitability of algal
biomass as a valuable feed supplement or substitute for
conventional animal feed sources [5]. Therefore, the usage
of microalgae biomass for feed productions will be dis-
cussed in this review which might be helpful to encourage
the trends of mass cultivation of microalgae for commer-
cial and beneficial purposes.
Astaxanthin
Astaxanthin, a carotenoid equipped with two asymmet-
ric carbon located at the 3 and 3΄ position of the ben-
zenoid rings on either end of the molecule, has been
proposed as super vitamin E due to its natural antioxi-
dant activities [6-8]. As a natural pigment, the major
market for astaxanthin is as pigmentation source in
aquaculture [9]. Natural astaxanthin can be produced by
Haematococcus microalgae, Chlorella zofingiensis, Chlo-
rococcum sp. and the yeast Xanthophyllomyces den-
drorhous [10-13]. Studies regarding effects on lipid
metabolism and antioxidant defense mechanisms re-
vealed that astaxanthin is responsible for lowering the
plasma lipid concentrations and enhancing antioxidant
defense in apolipoprotein E knockout mice [14]. The
increasing growth of salmonid farming has created an
enormous demand for natural astaxanthin as pigment.
Out of total carotenoid (astaxanthin, cantaxanthin),
the astaxanthin was determined as the most important
carotenoid in salmons and rainbow trouts [15]. Sal-
monid are unable to synthesize astaxanthin de novo,
therefore carotenoid pigments must be supplied in
their artificial aquaculture diet [16]. The carotenoid
pigment astaxanthin has important applications and is
routinely being used in the nutraceutical, cosmetics,
food and feed industries [17]. In aquaculture feed, it
has been used to culture salmon, shrimp, ornamentalfish and sea bream. A recent report showed that Hae-
matococcus pluvialis especially in dose of 3 g kg-1 feed
administration may effectively enhance the antioxidant
system and some biochemical parameters in rainbow
trout [18]. Astaxanthin is not responsible only to pro-
vide pigmentation but also has been attributed with
extraordinary potential for protecting the organism
against a wide range of diseases, and has considerable
potential and promising applications in human health
[13]. Natural astaxanthin was also found effective to
treat the patients with functional dyspepsia, caused by
Helicobacter pylori [7]. UV radiation from sunlight is
known as the most potent environmental risk factor in
skin cancer pathogenesis, astaxanthin has been demon-
strated as a protective tool against UVA-induced DNA al-
terations in human skin fibroblasts (1BR-3) [19].
Epidemiological studies have demonstrated a correl-
ation between increased carotenoid intake and reduced
incidence of coronary heart disease, certain cancer types,
macular degeneration, and increased resistance to viral,
bacterial, fungal and parasitic infection [20]. The price
for astaxanthin varies in the market and depends on the
percentage contents in algal source; however the over-




Lutein is another important carotenoid which can be
found naturally in algae. It is prominent in human
serum and foods [21]. Lutein has been used for the pig-
mentation of animal tissues and products, and it is con-
sidered important for the natural coloration of foods,
drugs and cosmetics. It has been documented that it
plays an active role in delaying chronic diseases, sti-
mulating the immune response, hampering the deve-
lopment of cataracts and the progression of early
atherosclerosis, and preventing blindness or decrease in vi-
sion caused by age-related macular degeneration [22-24].
Global lutein market in 2004 accounted for US$139 million
and was considered as the fastest projected growth in indi-
vidual carotenoids sales [3]. The recent market value of lu-
tein is ~US$233 million (2010), and is expected to reach
US$309 million by 2018 with a compound annual growth
rate of 3.6% (http://www.companiesandmarkets.com/
Market/Food-and-Drink/Market-Research/The-Global-
Market-for-Carotenoids/RPT988273). French marigold
(Tagetes patula) is currently the most widely applied
source for lutein production in the world. In the USA,
two lutein containing products, Aztec Marigold and Ta-
getes have been commercialized. Lutein is usually pro-
duced from three different marigold flowers (Tagetes
patula L.) (marigold orange, marigold yellow, and
marigold red) but the marigold orange (MGO) variety
Yaakob et al. Journal of Biological Research-Thessaloniki 2014, 21:6 Page 3 of 10
http://www.jbiolres.com/content/21/1/6contains the maximum amount of lutein [25]. How-
ever, mass plantation of marigold occupies a large land
area and it is easily influenced by seasonal and climatic
change [24]. Although an established commercial sys-
tem for the production of lutein from microalgae does
not exist yet, the basis for outdoor production of
lutein-rich cells of strains of Muriellopsis sp. and Sce-
nedesmus sp. at a pilot scale have already been set up
[3]. Recently, there has been remarkable interest in
dietary carotenoids with respect to their antioxidant
properties and their ability to reduce the chances of
some chronic diseases which occurred because of the
free radicals. Possibly, carotenoids protect cells from oxi-
dative stress by quenching singlet oxygen damage with a
variety of mechanisms. Therefore, algae derived carot-
enoids could be a leading natural resource in the search
of potential functional ingredients [26]. The microalgae
biomass from chlorophycean is also considered as the
major source of lutein, especially Chlorella sp., Scene-
desmus sp. and Muriellopsis sp. [3,24]. Laboratory stud-
ies showed that heterotrophically cultivated Chlorella
sp. produce considerable amount of lutein [27]. The
ability of heterotrophic growth in fermenters makes
Chlorella sp. a potential alternative resource for com-
mercial production of lutein [24]. Studies showed that
more lutein will be produced by Chlorella sp. using Basal
Medium compared to Kuhl Medium because of the high
concentration of EDTA and minerals (500 mg l-1:
9.3 mg l-1) [22]. On the other hand, Wu et al. [24] have
modeled lutein production by heterotrophic Chlorella sp.
in batch and fed-batch cultures as a potential alternative
source for commercial production.
Beta-carotene
Beta-carotene is a pigment of increasing demand and a
wide variety of market applications: as food coloring
agent, pro-vitamin A (retinol) in food and animal feed,
additive to cosmetics and multivitamin preparations, and
as a health food product under the antioxidant category.
The market value of beta-carotene was estimated about
US$253 million in 2009 [3]. According to a report on
the global market for carotenoids (September 2001), the
market value of beta-carotene was estimated at around
US$261 million in 2010 and this market is expected to
grow to US$334 million by 2018 at a compound annual




Because of limited supply from natural sources, a num-
ber of companies have introduced synthetically produced
carotenoids to meet the high demands in the global mar-
ket. Beta-carotene, a provitamin A is the only carotenoid
which has the potential to form two molecules of vitaminA (retinol) [28]. Natural production of beta-carotene can
be produced by the microalgae genus Dunaliella, strains
that have shown to change their color from green to or-
ange may produce and accumulate large amount of cellu-
lar beta-carotene [29]. Dunaliella sp. occurs in oceans,
brine lakes, salt marshes, salt lagoon and salt water ditches
near sea, predominantly in water bodies containing more
than 2 M salt and high level of magnesium. Dunaliella sp.
is recognized as being the most halotolerant eukaryotic
photosynthetic organism, showing a remarkable degree of
adaptation to variety of salt concentrations from as low as
0.1 M to salt saturation about 4 M [30]. The unicellular
halotolerant alga Dunaliella bardawil was shown to con-
tain high concentration of beta-carotene, composed of
the all-trans and the 9-cis isomers [28]. Beta-carotene
is a structural analogue of vitamin A and its topical ap-
plication can effectively be used to treat skin melasma
[31]. It has been reported that a daily dose of Duna-
liella sp. beta-carotene exerts a protective effect
against exercise induced asthma probably through
in vivo antioxidative effect [32]. Age-related macular
degeneration is one of the most common eye diseases
causing severe or permanent loss of vision, an antioxi-
dant therapy using combinations of high dosage anti-
oxidant vitamins C, E, beta-carotene, and zinc are
employed [33,34].
The price for natural beta-carotene depends on de-
mand varying from US$300 to US$3000 kg-1. Purified
beta-carotene is sold in vegetable oil form ranging from
1% to 20% of concentration depending on type of food
products. Naturally produced purified beta-carotene is
usually accompanied with other Dunaliella sp. caroten-
oid (carotenoid mix) which includes lutein, neoxanthin,
zeaxanthin, violaxanthin, cryptoxanthin, and α-carotene.
Variety of natural beta-carotene can be found for sale as
health food and supplement under vitamin section. In
powder form, natural beta-carotene is used for coloriza-
tion and pro-vitamin A for animal (cattle and poultry)
and aquaculture (shrimp and fish) feed [30].
Chlorophyll
Chlorophyll is a green pigment and is an extremely im-
portant biomolecule, critical in photosynthesis, which
allows plants to absorb energy from light for carbon di-
oxide fixation. The most green leaf material contains
about 0.3% chlorophyll and on extraction using conven-
tional methods yields about only 5%. Cheap sources, like
grass and lucerne (alfalfa), are usually selected as chloro-
phyll source [35]. In more esoteric extractions, leaves of
nettles and elder are preferred, whilst algae and silk worm
droppings have also been used commercially [36].
Structurally, chlorophyll is essentially two parts: a
substituted porphyrin ring known as an excellent chela-
ting ligand and a long carbon chain phytol [37]. Dietary
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rivatives including chlorophyll a and b. The structural
modifications of the chlorophyll pigments mainly the
de-esterification of phytol ring may significantly in-
crease (65-fold) its transfer from the food matrix to the
intestinal epithelial cells during digestion [38]. Sodium/
copper derivatives of chlorophyll are frequently used as
food additives or in beverages [39]. Sodium copper chloro-
phyllin is an approved food color in the USA (http://www.
accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.
cfm?fr=73.125). Besides that, it repairs cells, increases
hemoglobin in blood and promotes the cell growth [5].
Regarding the cytotoxity of chlorophyll derivatives, the
application of pheophorbide and pheophytin against
tumor cell revealed that the cellular uptake and inhib-
ition of myeloma cell multiplicity was greater for pheo-
phorbide than pheophytin, hence it indicates that
chlorophyll derivates may play a role in cancer preven-
tion [28]. Patients with chronic relapsing pancreatitis
can be treated with chlorophyll-α without any unfavor-
able side-effects, such as of allergic, or photosensitive,
or hepatotoxic nature [40].
Chlorophyll has also been investigated as potential
source of pigments in cosmetics; the brown and red
algae are mostly used in the cosmetic industries [5]. Fur-
thermore, in food industry, chlorophyll is used as natural
pigment ingredient in processed foods. Because of its
strong green pigment and consumer demand for natural
foods, chlorophyll is gaining importance as food additive.
This in turn is encouraging food processors to switch
from artificial pigments to chlorophyll-based natural col-
oring. However, a downstream process needs to be devel-
oped to purify chlorophyll a and b from algae [5].
Phycobiliproteins
Phycobiliprotein, a high-potential molecule, has been
utilized commercially as natural dyes and has a variety
of applications in pharmaceutical industry. It is classified
according to UV-visible absorption maxima as phyco-
cyanin (blue pigment), phycoerythrins (red pigment), and
allophycocyanin (pale-blue pigment). The annual market of
phycocyanin was around US$5-10 million [41]. The Cyano-
bacterium Spirulina sp. is a source of c-phycocyanins and
allophycocyanins and contains relatively low nucleic acid
content; is composed of 55%-70% protein, 6%-9% fat, and
15%-20% carbohydrate, and is rich in minerals, vitamins, fi-
bres, and pigments [42]. Another type of algae that can be
a source for phycobiliprotein is Aphanizomenon flos-aquae
[28,43]. Arthrospira sp. is a group of Cyanobacteria charac-
terized by loosely spiral shaped trichomes arranged in an
open helix enclosed in a thin mucilaginous sheath, usually
found in alkaline, brackish and saline waters. They usually
become predominant species and form massive blooms
[44]. The phycobiliprotein may be utilized for labelingantibodies in clinical tests (such as immunofluoress-
cence or flow cytometry) by binding to biologically ac-
tive molecules such as immunoglobulin, biotin or
protein [28,45]. Scientific studies have shown that the
synergistic action of a wide spectrum of antioxidants is
better than the activity of a single antioxidant, and that
antioxidants from natural sources (primarily foods) have
a higher bioavailability and therefore higher protective
efficacy than synthetic antioxidants [43]. It is reported
that phycocyanin acts as antioxidant against free radicals
and selenium and phycocyanin have been reported to
show potent cancer chemopreventive activities [46,47]. It
is proven that phycocyanin is 20 times more efficient than
ascorbic acid against hemolysis induced by peroxyl radi-
cals in human erythrocytes [28].
Polyunsaturated fatty acids (PUFAs)
Polyunsaturated Fatty Acids (PUFAs) include docosahex-
aenoic acid (DHA), eicosapentaenoic acid (EPA), arachi-
donic acid (AA), γ-linolenic acid (GLA) and have been
widely recognized as beneficial towards human health
[48]. According to a new technical market research re-
port “Global Market for Oleochemical Fatty Acids”
(CHM062A) from BCC Research (www.bccresearch.
com), the naturally produced fatty acid market was val-
ued at US$7.2 billion in 2011 and should reach US$6.9
billion in 2012. The total market value of fatty acids
expected to reach US$13 billion in 2017 (http://www.
slideshare.net/bccresearch).
Natural PUFAs can be obtained from fish or extracted
from fish oil. However, there is report on the possibility of
accumulated toxin in the PUFAs derived from fish sources,
furthermore the unpleasant smell, taste and poor oxidative
stability has limits the application of fish oil as food additive
[4]. Fish oil derived PUFAs have low oxidative stability and
the oxidative stability of DHA containing algae oils varies
widely depending on some physical parameters. However,
EDTA can be used to inhibit oxidation of foods containing
long-chain PUFA from either fish or algae and fortified with
iron [49]. Moreover, a recent study has shown that PUFAs
(450 mg day-1) are not being met by the diet in the majority
of the population; the current mean intake of PUFAs by
adults is estimated to be about 282 mg day-1 (EPA and
DHA contributing about 244 mg day-1) [48]. It is undeni-
able that microalgae can be the alternative natural source
for PUFAs; PUFAs found in fish are actually originated
from microalgae. However, DHA is the only algal PUFA
commercially available as an omega-3 fatty acid and has
been documented as a major structural fatty acid in the
grey matter of the brain [50]. DHA is important for correct
brain and eye development in infants and has been shown
to support cardiovascular health in adults [4,51]. DHA
helps body to fight against diseases and recent studies ex-
plore the significant role of PUFAs in the immune system
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(PPAR-α and PPAR-γ), and favorable effects of n-3
PUFA supplementation on allergic diseases and novel
therapeutic strategies to treat eosinophilic disorders
have also been reported [52].
Μarine microalgae have significantly higher DHA con-
tents compared to fresh water microalgae [5]. DHA is
found in a limited selection of foods such as fatty fish and
organic meat; it also occurs naturally in breast milk and its
concentration in breast milk might be influenced by envir-
onmental factors, however it is not available in cow’s milk
[53]. Since 1990, a number of health and nutrition organi-
zations have specifically recommended the inclusion of
DHA in infant formula for preterm and full term infants.
DHA is the characteristic PUFA of the marine dinoflagel-
lates. Crypthecodinium cohnii is a non-photosynthetic, mar-
ine dinoflagellate producing DHA predominantly [54].
Nearly 30-50% of its constituent fatty acids are C22:6 (n-3)
fatty acid and no other PUFAs are present in excess of 1%.
It is, thus easy to separate DHA from the fatty acid mix-
tures. For this reason, Crypthecodinium cohnii represents a
promising source for the commercial production of DHA
[55]. The world wholesale market for infant formula was
estimated to be about US$10 billion per year [56]. A num-
ber of food items containing PUFAs (including DHA) are
being sold in market [4]. Some algae-related heterotroph
strains that have high DHA such as Schizochytrium
mangrove, reported to have main component of DHA in
a range of 33-39% of total fatty acid while Amphidium
caryerea and Thrautocytrium aureum contain 17% and
16.1%, respectively [5].
Nannochloropsis sp. has been proposed as a source of
PUFAs due to its high contents of EPA [57]. Thus,
Nannochloropsis sp. production has been used to address
the rotifer requirements of 8 million gilt-head sea bream
fingerlings production annually [58]. Being suitable
for aquaculture industry, EPA too has been used as
nutritional supplement. The diatoms Phaeodactylum
tricornutum and Nitzschia laevis are algae strains to be
utilized as sources of EPA [4,59]. Chaetoceros muelleri
var. subsalsum and Isochrysis galbana have record per-
centage of DHA and EPA; they present the highest out-
put of EPA (3.5% and 4.8% on dry basis, respectively)
using vertical plate glass reactor [58,60]. EPA is an n-3
PUFA that plays an important role in the regulation of
biological functions and prevention and treatment
of a number of human diseases such as heart and
inflammatory diseases [61]. The eicosanoids are hormone-
like substances including prostaglandins (PG), throm-
boxanes (TX) and leukotrienes (LT). AA and EPA are
precursors of eicosanoid compounds. However, the eico-
sanoids from these two fatty acids are different structurally
and functionally, and are sometimes even antagonistic in
their effects. A balanced uptake of EPA/AA can preventeicosanoid dysfunctions and may be effective in treating a
number of illnesses and metabolic disorder [59]. Porphyri-
dium cruentum, a red alga, has been used for massive cul-
tures due to its relatively high AA and EPA concentration.
Nevertheless, Porphyridium cruentum biomass is high in
protein (34.1%), carbohydrates (32.1%) and essential min-
erals [62]. AA is potentially used for infant formulas (ei-
ther for full-term or preterm infants) and as nutritional
supplement [4].
Aside from phycobiliprotein, Arthrospira sp. is known
to be the richest algal source of GLA. GLA is important
to the infant formulas for full-term infant and has the
potential to lower low-density lipoproteins in hypercholes-
terolemic patients, alleviate the premenstrual syndrome
and treat atopical eczema [4,44]. GLA may attenuate the
signs and symptoms of inflammatory diseases such as
rheumatoid arthritis and atopic dermatitis [63,64]. From
both animal and human trials, it has been revealed that
dietary supplementation with GLA can modulate inflam-
mation [63].
Beta-1,3-glucan
Beta-1,3-glucanis considered responsible to initiate host
defense reactions in response to pathogen surface mole-
cules. The most important substance other than oil in
Chlorella sp. is beta-1,3-glucan. The world annual sales
of Chlorella sp. are in excess of US$ 38 billion [65]. Ini-
tially, beta-1,3-glucan was named as Zymosan in the
1940s in Norway. It was found in the cell wall of baker’s
yeast. Further studies have been conducted by Riggi &
Di Luuzio in 1961 [66] in Italy, and since then the bio-
active compound was renamed as beta-1,3-glucan. Fur-
ther studies on beta-1,3-glucan has been done in Japan
around 1970s. Beta-1,3-glucan is important to human
health. Feeding of immunostimulant beta-1,3-glucan to
healthy fish may raise the non-specific and specific im-
munity level and the protection against bacterial infec-
tion compared with the control [67]. Chlorella sp. is a
major source of beta-1,3-glucan [68]. Beta-1,3-glucan
had significant effect as a prophylactic treatment to re-
duce the anthrax infection in mice and the same type of
treatment can also inhibit the growth of cancer cells
in vivo by involving stimulation of three important cyto-
kines [69,70]. Positive effects were also found in patients
after cardiopulmonary bypass, and inhibition of antiviral
activity has been found in HIV-infected patients, more-
over beta-1,3-glucans are routinely used in patients for
tumor immunotherapy [71]. The use of beta-1,3-glucan
is of special interest in the cancer patient undergoing
chemotherapy and/or radiation treatment, since beta-
glucans have shown a remarkable ability to accelerate
hematopoetic recovery in both sublethally and lethally
irradiated mice. It can also stimulate recovery of the
bone marrow following chemotherapy, which is vital to
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plications during treatment. Amparyup et al. [72] showed
that pattern recognition proteins [including lipopolysac-
charide and beta-1,3-glucan binding protein (LGBP)]
could enhance the phenoloxidase activity in shrimp.
Pharmaceutical and nutraceutical compounds
Algae have the potential to be a source of compounds
having antibiotic and anticancer activity. A wide variety
of Cyanobacteria produce compounds including sulfoli-
pids that were active against herpes virus, pneumonia
virus and HIV [73,74]. Cyanobacteria can produce toly-
toxin (6-hydroxy-7-O-methylscytophycin B), an anti-
fungal antibiotic and highly toxic to mice [75,76]. The
marine cyanobacterium Lyngbya majuscula produces
aurilides B and C having cytotoxicity against human
lung tumor and mouse neuroblastoma cell line [77].
Moreover the macroalgae Laphocladia sp. is capable of
producing lophocladine alkaloids that exhibit cytotox-
icity to NCI-H460 human lung tumor and MDA-MB-
435 breast cancer cell lines [78]. Therefore, once the
algal sources of useful medicinal compound are identi-
fied, the algae can be cultivated in mass scale and the
material can be extracted, purified, and marketed [1].
Some microalgae species are established in the skin care
market, the main ones being Arthrospira sp. and Chlorella
sp. A number of cosmeticians have even invested in their
own microalgae production (http://www.fao.org/docrep/
012/i1704e/i1704e01.pdf). Two examples of commercially
available products and their properties claimed by their
companies are a) a protein-rich extract from Arthrospira
sp. that repairs the signs of early skin aging, exerts a
tightening effect and prevents stria formation [4] (Pro-
tulines, Exsymol S.A.M., Monaco) and b) an extract
from Chlorella vulgaris that stimulates collagen synthesis
in skin, thereby supporting tissue regeneration and wrinkle
reduction (Dermochlorella, Codif, St. Malo, France http://
www.coptis.com/site/desc.php?RefFab=1CDF). Recently,
two new products have been launched by Pentapharm
(Basel, Switzerland): a compound from Nannochloropsis
oculata is used for excellent skin-tightening properties
(short and long-term effects) (Pepha-Tight) and an ingre-
dient from D. salina is known to have the ability to mark-
edly stimulate cell proliferation and turnover to positively
influence the energy metabolism of skin (Pepha-Ctive) [4].
Livestock feed
Spirulina has been frequently used in feed supplements
due to its excellent nutrient compounds and digestibility
because it has small amount of carbohydrates. The livestock
feed is another useful product which may be obtained from
the algae, since many of algae species have been examined
for their biochemical compositions to evaluate their
suitability as a substitute or primary livestock feed [79].Spirulina has a unique blend of nutrients containing nutri-
ents that include B-complex vitamins, minerals, proteins,
gamma-linolenic acid and super anti-oxidants (such as
beta-carotene, vitamin E, trace elements) and a number of
unexplored bioactive compounds [80]. Compared to other
microorganisms, Spirulina sp. can be cultivated in high
saline water and alkaline conditions which give an advan-
tage to function as a feedstock for livestock feed [81]. Re-
cently, studies regarding growth and body conformation
responses of genetically divergent Australian sheep to
Spirulina (Arthrospira platensis) supplementation revealed
that Spirulina can increase live weight, growth and body
conformation significantly [82]. Feeding lipid-encapsulated
algae supplements may increase n-3 content in milk fat
without adversely affecting milk fat yield [83].
An algal supplementation level of about 10 g kg-1 of
dry matter intake proved to be effective in reducing milk
fat content and in modifying the milk fatty acid compos-
ition toward increased conjugated linolenic acid (CLA)
and DEA concentrations [84]. A related study demon-
strated that dietary supplementation with fish meal or n-3
PUFAs in early-lactating dairy cows significantly increased
milk yield with no change in milk composition [85]. In
addition, some sea weeds like red algae (e.g. Porphyra sp.,
Gracilaria sp. and Kappaphycus sp.) and brown algae
(particularly Laminaria sp., Undaria sp. and Hizikia
fusiforme) were used in human food exhibiting potential
to be used for livestock feed. Porphyra sp., Gracilaria sp.,
Grateloupia sp., and Kappaphycus sp. have also been
genetically transformed for enhanced production of re-
spective products [86]. The annual Porphyra sp. harvest
worldwide has been estimated to be worth of US$2.5 bil-
lion. Porphyra sp. primarily contains vitamin A, vitamin B,
vitamin C, beta-carotene, as well as essential minerals
including iodine. Besides that, a study on Laminaria
digitata suggested that algae supplemented feed has in-
creased the pig weight up to 10% on a daily basis [1,5].
Poultry feed
There are more chickens in the world than any other
bird; in fact, more than 50 billion chickens are reared
annually as a source of food, for both their meat and eggs
(http://www.ciwf.org.uk/farm_animals/poultry/). Compre-
hensive analyses and nutritional studies have demon-
strated that algae contain proteins and these proteins
are of high quality and comparable to conventional vege-
table proteins [87]. Ginzberg et al. [88] studied the role of
algae Porphyridium sp. as feed supplement on metabolism
of chicken. It was found that cholesterol of egg yolk was
reduced about 10% and color of egg yolk became darker,
indicating the production of higher carotenoids [5,89]. In
poultry rations, algae up to a level of 5-10% can be used
safely as partial replacement for conventional proteins.
Prolonged feeding of algae at higher concentrations may
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and shanks as well as of egg yolk is the most important
characteristic that can be influenced by feeding algae.
Moreover, the Institute für Getreideverarbeitung (Bergholz-
Rehbrücke, Germany) produces a natural feed with the
algae Chlorella sp. and Arthrospira sp. called Algrow [90].
Aquaculture feed
Demand for fish for human consumption has risen due
to the environmental concerns over Open Ocean fishing
[91]. The world market for farmed fish and aquatic edible
plants was valued in 2008 at US$106 billion. Products
from fisheries and aquaculture combined are supplying
the world with 142 million tonnes of protein every year
(http://www.blueeconomy.eu/m/articles/view/Fish-with-
out-Feed-Part-1-The-Market).
According to another report by United Nations Food
and Agriculture Organization (www.fao.org/docrep/016/
i2727e/i2727e.pdf ), in the last three decades (1980-
2010), world food fish production of aquaculture has in-
creased by almost 12 times, at an average annual rate of
8.8% and the world aquaculture production attained an-
other all-time high in 2010 at 60 million tonnes (excluding
aquatic plants and non-food products), with an estimated
total value of US$119 billion (http://aquabounty.com/aqua-
culture-market/). Non-toxic marine microalgae, including
the stramenopiles Isochrysis sp., Pavlova sp. and Nanno-
chloropsis sp. as well as various diatoms, represent the pri-
mary food source at some stages in the life cycle of most
cultivated marine animals [1]. Therefore, algal biomass will
be in high demand for the fish-food and aquaculture mar-
kets in the future and provide ample revenues for the algae
industry [91].
A challenge in fish nutrition is to generate end products
with high levels of health-promoting long chains of
omega-3 fatty acids for the consumer, while reducing the
use of fish oils. Omega-3 oils have a high market demand
in both the human nutraceuticals and animal feed indus-
tries. This growing trend is an additional driving force for
the marketing of non-marine-based omega-3 oils and al-
ternative feed ingredients. Algae is a rich source of high
quality protein, vitamins, micronutrients (trace elements),
and carotenoids, Long-chain PUFAs, especially of n-3 and
n-6 series such as eicosapentaenoic (EPA), docosahex-
aenoic (DHA), and arachidonic (AA) are considered
pharmacologically important for dietetics and thera-
peutics [90]. Algal meal is a rich source of high-quality
protein, vitamins, micronutrients (trace elements) and
carotenoids, which can be used directly in aqua feeds
[85]. Furthermore, fish phosphoglycerides generally
contain 50% of their total fatty acids as n-3 PUFA with
a ratio of 22:6 (n-3):20:5 (n-3) of about 2:1 and it can
be seen most clearly in the phosphoglycerides of fish
eggs [59]. In addition, better growth weight andprotein efficiencies ratio of tilapia was observed when
supplied with algae as nutritional source in feed. Also,
Phorphidium valderianum was successfully used as
feed for aquaculture (based on its nutritional performance
and non-toxic properties) [5]. The diatom Thalassiosira
pseudonana is widely cultivated to feed variety of mol-
lusks, including the Pacific oyster Crassostrea gigas and
rock scallops [1]. The long chain PUFAs are highly sus-
ceptible to oxidation because of their unsaturated nature;
the addition of natural antioxidants to the highly unsatur-
ated fish oil may protect it from oxidation [92].
Shrimp feed
The total global production of farmed shrimp reached
more than 1.6 million tonnes in 2003, representing a value
of nearly US$9,000 million (http://fisherymanagement.
wikia.com/wiki/Shrimp_farm). Shrimp farming produc-
tion reached 737,200 tonnes in 1998, an increase of 12%
from 1997. This increased production was mainly re-
ported in subtropical regions of America (28%, 457 hatch-
eries) and SE Asia (72%, 3,718 hatcheries) [59]. According
to Shrimp Production Review by Food and Resource
Economics Department, University of Florida USA, the
shrimp farming was estimated to be about 4 million
metric tonnes in 2013, with 10.3% projected annual growth
rate (mainly attributed to SE Asian countries and China)
(http://www.gaalliance.org/update/GOAL11/DiegoValder-
rama.pdf). However, disease outbreaks in recent years
have affected farmed Atlantic salmon in Chile, oysters
in Europe, and marine shrimp farming in several countries
in Asia, South America and Africa, resulting in partial or
sometimes total loss of production (http://www.fao.org/
docrep/016/i2727e/i2727e.pdf ). In 2010, aquaculture in
China suffered production losses of 1.7 million tons
caused by natural disasters, diseases and pollution. Dis-
ease outbreaks virtually wiped out marine shrimp farming
production in Mozambique in 2011 (www.fao.org/docrep/
016/i2727e/i2727e.pdf). Microalgae species Hypnea cervi-
cornis and Cryptonemia crenulata particularly rich in pro-
tein were tested in shrimp diets. Amount of algae in fish
meal resulted in significant increase in shrimp growth rates
[5]. The requirement for DHA in marine fish and shrimp
nutrition has been established via feeding diets containing
DHA and AA; the findings revealed that shrimp rose on di-
ets rich in DHA and AA showed significant improvement
in immune parameters, such as total hemocyte count, phe-
noloxidase activity, superoxide dismutase activity, and bac-
tericidal activity [93]. Recently, it has been reported that the
addition of 0.5% Spirulina meal in a complete diet for
shrimp (L. vannamei juveniles), with 14% of Peruvian fish-
meal, has proved as a nutritionally efficient feeding attract-
ant [94]. Through short-term feeding studies, two marine
algal products (MAP) named MAP3 and MAP8 were
found suitable as substitute of protein source in the feeds of
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the utilization of fish oil and algae as a source of PUFAs are
going side by side but the trends are more inclined towards
algal products. Menhaden fish oil can also be used as a
source of dietary fatty acids which influence the compos-
ition of Pacific white shrimp muscle tissue by exhibiting sig-
nificantly higher shrimp muscle DHA level [95]. As fish
meal content, DHA is required for the production of ecdys-
one for molting, growth and egg production. The mechan-
ism involves the biological membranes rich in di-22:6 (n-3)
phosphoglycerides which is relatively constant in the face of
changing environmental variables like temperature, pres-
sure, and salinity [59].
Conclusion
Microalgae have multiple potential to produce high-valued
products and there is an urgent need of awareness makes
these biomolecules popular in the world to meet the in-
creasing demands with respect to population. Most of these
biomolecules are not produced in the animal/human body
but termed as essential; therefore, it is highly recommended
to make these biomolecules available for food and feed pur-
poses. Although the production of biomolecules from algae
requires some awareness regarding technology and market
value at the industrial and farmer level, it has been proved
that these biomolecules can be produced using algae as a
potential source at small or large scale. The demanding
market of these biomolecules is quite convincing to stimu-
late research interests leading to production programs by
the related organizations. Algae culturing got attention be-
cause of its biofuel producing characteristics but the aware-
ness regarding cultivation technologies may also lead to set
trends for biomolecule production as a pharmaceutical or
nutritional product. The production of biomolecules from
algae and their subsequent utilization in animal and aqua-
culture feed may support the objectives to establish indus-
try from microalgae at domestic or industrial scale. Some
of the biomolecules can be produced as a byproduct while
producing biofuel from algae as a main targeted product.
Eighty-two percent of the world fish stocks are over-
exploited, depleted or endangered, while demand for fish
protein is exploding. With the world population expected
to reach 9 billion by 2050, demand for critical sources of
protein continues to outstrip supply.
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